When investing in maternity insurance, check the waiting period clause and review coverage limits for prenatal and postnatal ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

As a first-time parent, protecting your baby’s health is your top priority—and vaccinations are one of the most effective ...

According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for ...

In an interview, Antoni Vilaseca Cabo, MD, discussed the clinical activity of TAR-210 in patients with non-muscle invasive ...

Details on the late-breaking abstract and posters are as follows: Cretostimogene is an investigational, intravesically delivered oncolytic immunotherapy being evaluated in BOND-003, a Phase 3 clinical ...

KEYTRUDA, as a single agent, is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma: KEYTRUDA, as a single agent, is indicated for the treatment of ...

ImmunityBio (IBRX) announced new data from its ongoing QUILT 3.032 study. As of November, 100 patients with Bacillus Calmette-Guerin, or ...

The Department of Health on Tuesday launched a catch-up vaccination drive to increase the fully-immunized children (FIC) ...

The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

Research analysts at Cantor Fitzgerald increased their FY2024 EPS estimates for shares of CG Oncology in a research note issued on Wednesday, November 13th. Cantor Fitzgerald analyst J. Schimmer now ...

Equities researchers at Lifesci Capital upped their FY2024 EPS estimates for CG Oncology in a research note issued on Tuesday ...